We are live on ! Find out more
RP

Rowlandmiller & Partners Portfolio holdings

AUM $549M
1-Year Est. Return 36.2%
This Fund
S&P 500
This Quarter Est. Return
-0.62%
1 Year Est. Return
+36.2%
3 Year Est. Return
+84%
5 Year Est. Return
+107.35%
10 Year Est. Return
+338.51%
AUM
$479M
AUM Growth
-$13.8M
Cap. Flow
-$4.26M
Cap. Flow %
-0.89%
Top 10 Hldgs %
39.27%
Holding
193
New
9
Increased
47
Reduced
69
Closed
8

Top Buys

Rank Stock Value
1
SMCI icon
Super Micro Computer
SMCI
+$562K
2
VRT icon
Vertiv
VRT
+$474K
3
CVX icon
Chevron
CVX
+$323K
4
PSX icon
Phillips 66
PSX
+$198K
5
T icon
AT&T
T
+$181K

Top Sells

Rank Stock Value
1
PGR icon
Progressive
PGR
+$997K
2
LLY icon
Eli Lilly
LLY
+$662K
3
INTC icon
Intel
INTC
+$461K
4
HD icon
Home Depot
HD
+$392K
5
ADP icon
Automatic Data Processing
ADP
+$376K

Sector Composition

Rank Sector Weight
1 Technology 24.45%
2 Financials 16.08%
3 Healthcare 12.22%
4 Industrials 11.44%
5 Consumer Staples 10.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPS icon
26
United Parcel Service
UPS
$88.6B
$5.24M 1.1%
41,581
-105
-0.3% -$13.8K
COST icon
27
Costco
COST
$422B
$4.69M 0.98%
5,117
-282
-5% -$262K
TROW icon
28
T. Rowe Price
TROW
$23.9B
$4.66M 0.97%
41,221
-2,258
-5% -$261K
SYY icon
29
Sysco
SYY
$40.8B
$4.63M 0.97%
60,602
-71
-0.1% -$5.43K
AMGN icon
30
Amgen
AMGN
$208B
$4.57M 0.96%
17,548
-567
-3% -$168K
PAYX icon
31
Paychex
PAYX
$41.6B
$4.29M 0.9%
30,588
-76
-0.2% -$10.8K
CTAS icon
32
Cintas
CTAS
$81.9B
$4.26M 0.89%
23,309
-1,131
-5% -$238K
INTC icon
33
Intel
INTC
$455B
$4.23M 0.88%
211,113
-20,472
-9% -$461K
MRK icon
34
Merck
MRK
$322B
$4.23M 0.88%
42,548
-1,000
-2% -$103K
COP icon
35
ConocoPhillips
COP
$147B
$4.12M 0.86%
41,588
+416
+1% +$44.2K
WY icon
36
Weyerhaeuser
WY
$18B
$4.06M 0.85%
144,060
-2,785
-2% -$86.9K
WERN icon
37
Werner Enterprises
WERN
$2.24B
$3.91M 0.82%
108,747
-528
-0.5% -$20.2K
EMR icon
38
Emerson Electric
EMR
$83.9B
$3.22M 0.67%
26,013
-1,064
-4% -$129K
PKG icon
39
Packaging Corp of America
PKG
$21.9B
$3.21M 0.67%
14,263
-133
-0.9% -$30.8K
GILD icon
40
Gilead Sciences
GILD
$162B
$3.14M 0.66%
33,975
+42
+0.1% +$3.78K
SON icon
41
Sonoco
SON
$5.57B
$3.06M 0.64%
62,598
-411
-0.7% -$21.2K
WM icon
42
Waste Management
WM
$90.6B
$3.04M 0.64%
15,088
AFL icon
43
Aflac
AFL
$64.9B
$3.03M 0.63%
29,297
-2,076
-7% -$226K
CSX icon
44
CSX Corp
CSX
$93.4B
$3M 0.63%
92,901
+23
+0% +$789
TECH icon
45
Bio-Techne
TECH
$11.2B
$2.92M 0.61%
40,490
-580
-1% -$42.6K
KMB icon
46
Kimberly-Clark
KMB
$36.3B
$2.83M 0.59%
21,578
-30
-0.1% -$4.09K
VRT icon
47
Vertiv
VRT
$93B
$2.82M 0.59%
24,864
+3,993
+19% +$474K
DUK icon
48
Duke Energy
DUK
$97.8B
$2.82M 0.59%
26,216
-99
-0.4% -$11.2K
IDCC icon
49
InterDigital
IDCC
$7.87B
$2.45M 0.51%
12,657
-430
-3% -$75.2K
TXN icon
50
Texas Instruments
TXN
$252B
$2.28M 0.48%
12,186

Similar funds

Rowlandmiller & Partners's Q4 2024 Portfolio in Review

As of Q4 2024, Rowlandmiller & Partners held 193 positions worth $479M, down 2.8% from $492M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Rowlandmiller & Partners's Q4 2024 filing shows 9 new, 47 increased, 69 reduced and 8 closed positions. Its largest new stake was Humacyte: 31,500 shares worth $159K. The largest sale was Progressive, an estimated $997K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Rowlandmiller & Partners's largest Q4 2024 buy was Humacyte: 31,500 shares worth $159K.
  • Rowlandmiller & Partners added most to Super Micro Computer in Q4 2024, an estimated $562K increase.
  • Rowlandmiller & Partners's biggest Q4 2024 reduction was Progressive, cutting an estimated $997K.
  • Rowlandmiller & Partners fully exited Simon Property Group in Q4 2024, selling an estimated $169K.
  • Rowlandmiller & Partners's ten largest holdings make up 39% of its $479M portfolio in Q4 2024.
  • Rowlandmiller & Partners opened 9 new positions and closed 8 in Q4 2024.
  • Rowlandmiller & Partners's portfolio value fell 2.8% quarter-over-quarter to $479M.

Based on Rowlandmiller & Partners's 13F filing for Q4 2024, filed 4 Feb 2025.